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Identity 
Alias: Ataxia-telangiectasia, variant VI; Seemanova 
syndrome II; Microcephaly with normal intelligence, 
immunodeficiency, lymphoreticular malignancies; 
Immunodeficiency, microcephaly, chromosomal 
instability 
Note: Belongs to the group of inherited chromosomal 
instability syndromes: 
- Bloom's syndrome,  
- Fanconi's disease,  
- Ataxia telangiectasia (AT); see also, in Deep Insight 
section: Ataxia-Telangiectasia and variants. 
Inheritance: Autosomal recessive disease; since the 
recognition of the Nijmegen breakage syndrome (NBS) 
in 1981, about 50 patients are included in the NBS 
Registry in Nijmegen; the disease appears to have 
originated in central Europe, in the Slavic population, 
and to have spread through a founder effect. 
Clinics 
Note 
The condition is characterised by growth and mental 
retardation, craniofacial dysmorphy, ovarian failure, 
immunodeficiency, chromosome instability, 
predisposition to lymphoid malignancies, and 
radiosensitivity. 
Phenotype and clinics 
- Growth and mental development: 30% of children 
have low birth weight and short stature, and 75% a 
head circumference at birth below the 3rd percentil; 
all patients develop a severe microcephaly during the 
first months of life; mental development is normal in 
35% of the patients, moderately retarded in the othrs, 
though the mental retardation appears to be 
progressive; cerebellar ataxia is absent; 
alphafoetoprotein levels are normal, in contrast to AT 
patients. 
- Craniofacial dysmorphy: progressive and severe 
microcephaly, "bird-like" face with prominent midface, 
long nose and receding mandible.  
- Immunodeficiency: severe combined deficiency with 
agammaglobulinemia, IgA, IgG2 and IgG4 
deficiencies, decreased CD3+ and CD4+ lymphocytes, 
and decreased CD4+/CD8+ ratio; these disturbances 
are responsible of frequent respiratory, gastrointestinal 
and urinary infections. 
Neoplastic risk 
High frequency and early development of lymphomas, 
more often involving B-cells, in contrast with those 




- Lymphocyte cultures often show low mitotic index.  
- Structural chromosome aberrations are observed in 
10-30% of metaphases; most of the rearrangements 
occur in or between chromosomes 7 and 14, at bands 
7p13, 7q35, 14q11, and 14q32, as in AT; these bands 
contain immunoglobulin and T-cell receptor genes; the 
most frequent rearrangement is the inv(7)(p13q35). 
Other findings 
Note 
Radiosensitivity: increased sensitivity of both 
lymphocytes and fibroblasts to ionising radiations and 
radiomimetics, radio-resistant DNA synthesis. 
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Description: 16 exons. 
Protein 
Function: The product of NBS1, nibrin (p95), should 
have a role in the control of double-strand DNA breaks 
involved, for example, in VDJ joining in 
immunoglobulin and T-cell receptor genes 
recombination process, in meiotic recombination, and
in radio-induced DNA lesions; this suggests that nibri  
and the product of ATM could act in a common 
pathway of detection or repair of double-strand breaks; 
nibrin/p95 is found associated with Rad50 and Mre11 
at sites of DNA double-strand breaks. 
Mutations 
Germinal: All Nijmegen patients show truncating 
mutations. 
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